Sarcopenia Common in Rheumatoid Arthritis Patients
A study of nearly 1,000 rheumatoid arthritis patients found that 18.6% also suffer from sarcopenia, a condition involving the loss of muscle mass and strength. The research suggests that certain biologic drugs may help protect against this muscle loss.
Why it matters
Identifying risk factors for sarcopenia in arthritis patients can improve clinical management and long-term quality of life for those with chronic inflammatory conditions.
NEARLY one in five people with rheumatoid arthritis also has sarcopenia, the progressive loss of muscle mass and strength, a study of almost a thousand patients finds, identifying who is most at risk and hinting that some biologic drugs may protect against it.
The article is a straightforward summary of medical research findings.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in